#253: Platform Technology Designation: Opportunities and Challenges for Implementation
Tuesday, June 18, 2024 1:15 PM to 2:15 PM · 1 hr. (US/Pacific)
Room 6B
09: Regulatory
Information
This forum will review the key components of the new FDA Platform Technologies Designation program. A panel of experts will provide their perspectives on the proposal and discuss opportunities and challenges related to its implementation.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Digital Technology
Speakers
Naoko Hagimori
Medical Research and Innovation groupTranslational Research Center for Medical Innovation
Evdokia Korakianiti
Head of Quality and Safety of MedicinesEuropean Medicines AgencyAD
Andrea Doyle
GRA Head, Region North America, Global Advertising and PromotionSanofiRA
Rachael Anatol
Deputy Super Office Director, Office of Therapeutic Products, CBERFDA
